Cleveland BioLabs
CBLI
#9905
Rank
HK$0.38 B
Marketcap
HK$24.84
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -HK$21.36 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are HK$0.63 Million. In 2020 the company made an earning of -HK$20.13 Million a decrease over its 2019 earnings that were of -HK$18.5 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-HK$21.36 Million6.11%
2020-HK$20.13 Million8.8%
2019-HK$18.5 Million-50.81%
2018-HK$37.62 Million-14.3%
2017-HK$43.89 Million-11.88%
2016-HK$49.81 Million-50.9%
2015-HK$0.11 Billion-10.24%
2014-HK$0.12 Billion-37.5%
2013-HK$0.19 Billion-23.2%
2012-HK$0.24 Billion19.68%
2011-HK$0.2 Billion133.81%
2010-HK$84.14 Million68.22%
2009-HK$50.02 Million-55.51%
2008-HK$0.12 Billion-45.62%
2007-HK$0.21 Billion255.63%
2006-HK$58.13 Million198.18%
2005-HK$19.5 Million-1.25%
2004-HK$19.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$128.13 B-594,165.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$201.63 B-934,906.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$70.33 B-326,196.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.33 B-279,814.16%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$73.09 B-338,984.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$77.54 B-359,611.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$96.93 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA